Acrylonitrile (CH 2 =CH-CN, vinyl cyanide, VCN), ranks 39th on the list of chemicals produced in the United States (Reish, 1992) . Because of its structural similarity, methacrylonitrile [CH 2 =C(CH 3 )CN, MeVCN] is used as a replacement for VCN in the production of plastics, elastomers, and coatings and in the manufacture of carbonated beverage containers (Farooqui and Mumtaz, 1991) .
VCN is a suspected human carcinogen (EPA, 1983; O'Berg, 1980; Delzell and Monson, 1982; O'Berg et ai, 1985; Ward and Starr, 1993) . VCN-induced tumors in the brain, stomach, and zymbal's gland of exposed rats (Maltoni et ai, 1977; Quast et ai, 1980a,b) . VCN induces adrenal necrosis, gastrointestinal injury, central nervous system dysfunction, and congestive lung edema (Dudley and Neal, 1942; Paulet and Desnos, 1961; Szaboer ai, 198O; Ghanyem and Ahmed, 1983; Ahmed et ai, 1992) . MeVCN is toxic to animals following various routes of exposures (Pozzani et ai, 1968; McOmie, 1949; Kurzalieve and Zueve, 1988) . MeVCN is known to induce neurotoxicity in rats (Cavazos et ai, 1989) . The teratogenic and carcinogenic potential of MeVCN are currently unknown. The microsomal oxidation of VCN to cyanoethylene oxide has been established (Abreu and Ahmed, 1980; Guengerich et ai, 1981; Ahmed and Patel, 1981; Roberts et ai, 1989) . Conjugation with glutathione (GSH) has been suggested as the major detoxication pathway of VCN and its reactive metabolites (Ghanayem and Ahmed, 1982; Ahmed et ai, 1982; Kedderis et ai, 1993) . Both VCN (Szabo et ai, 1977) and MeVCN (Day et ai, 1988) deplete GSH in vivo, by varying degrees. Studies on the metabolism of methacrylonitrile suggest similar metabolic pathways that involve (1) microsomal P450 oxidation of the vinylic double bond to an epoxide that rearranges to form acetone, and (2) GSH conjugation (Tanii and Hashimoto, 1984; Cavazos et ai, 1989; Farooqui et ai, 1990; Ghanayem et ai, 1992) . Ahmed et ai (1983) have studied the biological fate of 2,3-[' 4 C]VCN and demonstrated that the blood and gastrointestinal tissues retained high levels of radioactivity. The distribution of 1-[ I4 C]VCN in rats and monkeys was studied using whole-body autoradiography (WBA) (Sandberg and Slania, 1980) . They reported high uptake of radioactivity in blood, liver, and kidney. This study, however, used VCN molecules that were labeled on the cyanide moiety. The latter can be lost via metabolism, and such labeling provides least information on the biological fate of the parent molecule. In the present study labeling of VCN by 14 C is on the second carbon. Recent studies on the disposition of MeVCN in rats indicate that, unlike VCN, MeVCN and its metabo-lites are extensively eliminated in the expired air of treated animals (Ghanayem et al., 1992; Burka et al., 1994) .
Metabolic and distribution studies of environmental chemicals define important mechanistic information that is needed to identify the target organs of toxicity and to establish modalities for protection from or cure of adverse effects of these chemicals. Furthermore, the role of structure-activity relationships in the metabolism, distribution, interaction, and elimination of environmental chemicals is of great value in future risk assessment determinations. Thus, the objective of the present study is to evaluate the differential disposition of VCN and MeVCN using WBA. The information thus obtained will help to explain the effect of methyl substitution, at the a vinylic carbon atom of VCN to form MeVCN, on the disposition of these chemicals.
MATERIALS AND METHODS

Chemicals. 2-[
l4 C]VCN (spec act, 7.35 mCi/mmol; punty, 97 5%) was purchased from Chemsyn Science Lab (Lenexa, KS). Radiochemical purity of 2-[' 4 Cl VCN was confirmed by gas chromatographic analysis (HP-5710A, equipped with flame ionization and radioactivity detectors, using a Porapak QS column and isothermal conditions at 135°C). 2-[
14 C]MeVCN (spec act, 1.8 mCi/mmol; purity, 98 7%) was purchased from Amersham Corporation (Chicago, IL). Radiochemical punty of 2-[ l4 C]MeVCN was also determined by gas chromatographic analysis (PU-4500 equipped with flame ionization and radioactivity detectors using a 10% Carbowax 1540 column on Chromasorb WAW DMCS and a temperature gradient of 5O-I7O°C for 15 min). Carbosorb II was obtained from Packard Instruments Company, Inc. (Downers Grove, IL). Tru-Count was purchased from Tru-Lab Supply Company (Libertyville, IL). Specific activity of the dosing solution was determined in a Beckman Model LS 1801 liquid scintillation counter (Irvine, CA). All other chemicals were of the highest purity commercially available. The experiments were conducted in well-ventilated laboratory hoods Animal care and treatment. Fischer (F.344, Inbred, CDF-crl BR) rats (5 weeks old, 1 10-I 15 g) were obtained from Charles River Laboratories (Wilmington. MA) The animals were acclimated in our animal facility for I week with a 12-hr light/dark cycle with free access to Purina rat chow and water ad libitum.
Aqueous dosing solutions of both chemicals were freshly prepared and immediately used to prevent possible polymerization or degradation of the radioactive compounds. Sixteen rats were divided into four groups (one group for each period), and each rat received an intravenous dose of 2-( l4 C]VCN solution (50 j/Ci/kg equivalent to I 1.5 mg/kg or 0 216 mmol/ kg). Another 16 rats (four groups) were similarly administered an intravenous dose of 2-| l4 ClMeVCN (50 j/Ci/kg equivalent to 14.5 mg/kg or 0.216 mmol/kg).
Exhalation and excretion study. Immediately following treatment, rats from each experimental group were placed in glass metabolism cages (two rats per cage) (Lab Glass International. Inc.. Vineland. NJ) for the collection of expired air. urine, and feces. Compressed breathing air was passed through the metabolism chambers at a flow rate of I liter/min. Air leaving the chambers was passed through Carbosorb II to trap expired I4 CO 2 . and then through acetonitrile to absorb organic exhalants such as either unmetabolized 2-[ l4 C]VCN or 2-[' 4 C]MeVCN. The trapping solutions were changed every 15 min for the first hour, every 30 min in the following 5 hr, and every 4 hr up to 48 hr. For the determination of radioactivity in the trapping solution, 0.1-ml aliquots from each collection period were added to 5 ml Tru-Count and counted using liquid scintillation spectrometry.
Unne and feces were collected into separate compartments in the metabolism cages. Unne was collected 8, 24, and 48 hr and fecal material was collected 24 and 48 hr after dosing. For determination of radioactivity in the urine, 0.1 ml urine from each collection period was added to 5 ml TruCount and the radioactivity was counted. Fecal matenal (100 mg) was dissolved in 10 ml Protosol (NEN Research Products, Boston, MA) by heating at 60°C for I hr. Aliquots (0.2 ml) of this solution was added to 5 ml Tru-Count and its radioactivity content was determined.
Whole-body autoradiography. Whole-body autoradiography was carried out on all treated animals in different groups as described before (Ullberg, 1977) . Rats were euthanized by CO 2 5 min, 8, 24, and 48 hr following treatment with either compound and immediately frozen at -70°C in a dry ice/hexane mixture. Frozen carcasses were then embedded in carboxymethyl cellulose (CMC) gel. The CMC gel molds were again immersed in dry ice/hexane mixture at -70°C for 20 min. The frozen molds were stored at -20°C until sectioning. Multiple sagittal sections of 30-/zm thickness were cut with a large cryomicrotome (PMV 2250, Sweden) maintained at -20°C. Whole-animal sections were mounted on Scotch tape 800 (3M Co., St. Paul, MN). For the registration of radioactivity, the sections were freeze-dried at -20°C for 3 days and dried over Dnente in wooden boxes. Autoradiographs were developed 30 days after exposing the mounted whole-animal sections to Industrex AA 2 X-ray films (Kodak Industries, Rochester, NY) along with precalibrated I4 C standards (Microscales, Amersham).
Irreversible interaction of radioactivity in whole-body sections. The radioactivity denved from 2-[ l4 C]VCN or 2-[' 4 C]MeVCN that is covalently bound to or metabolically incorporated into tissue macromolecules (proteins and/or nucleic acids) was determined using conventional acid-extraction techniques . Bnefly, whole-animal sagittal sections (30 fj.m), were cut and mounted to Scotch Tape No. 688 (Leila, Deerfield, IL). The freeze-dried sections were gently heated (40°C) on a hot plate and extracted by stepwise washings, in the following order (I) water for 15 min and (2) 10% trichloroacetic acid for 2 min, followed by I min each wash using (3) 50% methanol, (4) butanol, and (5) 100% heptane, respectively. The total volume of each solution used was 500 ml, and the sections were carefully agitated manually. This washing procedure was designed to remove water-soluble, acid-soluble, and as lipophilic radioactive molecules from the sections. Sections were then air-dried and incubated with AA 2 -Industrex film along with I4 C reference strips and developed as described earlier.
Representative autoradiographs were used as negatives for the production of pictures (Figs 1-5). White areas in the figures represent sites of high concentration of radioactivity and the gray intensity is indicative of lower levels of radioactivity.
Computer-aided image analysis of WBA. The disposition of nonvolatile and covalently bound radioactivity derived from 2-[' 4 C]VCN or 2-| l4 C]MeVCN was quantified using computer-aided image analysis of the autoradiographs (Ahmed et al., 199la.b) . Autoradiographs from each animal were selected to represent the maximum number of clearly identifiable organs and were studied in detail for the distribution of radioactivity. Quantitative optical densities for different organs and tissues in the autoradiographs were determined with an autoscanning image analyzer (MCID, Imaging Research Inc., Brock University, St. Cathenne. Canada)
Bnefly, by digitizing a series of autoradiographed radioisotopic standards, a response curve relating the level of radioactivity with the digitized number (an arbitrary number for the gray level produced by the video camera) was constructed. The computer used this information to calculate the actual amount of radioactivity in each pixel (picture-element) of the digitized image and performed a polynomial fitting to the standard calibration curve. The quantified image of the autoradiograph was then displayed by color coding 16 different levels of activity. Regions of interest were then selected and several (more than 10) pixels from each region were sampled and converted to nanocuries per gTam using the calibrated autoradiographic standard curve. The means and standard deviations were calculated from these values. The radioactivity in the blood was determined in cryosections of cardiac arteries and/or abdominal aorta.
Statistical analysis. Statistical analysis was performed using Student's t test and ANOVA when needed. Values were considered statistically significant if p =s 0.05.
RESULTS
Distribution of Radioactivity 5 min Following Treatment
The radioactivity derived from 2-[ l4 C]VCN was rapidly transferred from blood to organs 5 min after treatment (Fig.  la, Table 1 ). At this period, the lung had the highest levels of I4 C followed by intestinal contents, liver, and spleen. Rapid uptake of radioactivity was also observed in the thyroid, bone marrow, skin, adrenal gland, and gastrointestinal mucosa. Renal cortex contained a lower level of I4 C uptake than renal pelvis. Compared with other tissues, brain, spinal cord, and the testis contained the lowest levels of I4 C. Distinctive spotty deposition of I4 C in the adipose tissues and an overall granular appearance in the connective tissues were observed. High uptake of radioactivity derived from 2-[ 14 C]-MeVCN, 5 min following treatment, was found in the lung, nasal turbinates, and liver (Fig. lb, Table 2 ). Rapid and high uptake of M C was also observed in adrenal cortex and thyroid gland. Blood vessels and the heart contained considerable levels of radioactivity. Brain, spinal cord, and testis registered low levels of 2-[' 4 C]MeVCN-derived radioactivity. In comparison, 5 min following treatment, the overall tissue uptake of radioactivity derived from 2-[ l4 C]VCN was higher than that derived from 2-[ 14 C]MeVCN; however, the uptake of radioactivity in the adrenal, thyroid, and salivary glands, thymus, and nasal turbinates was higher in 2-[' 4 C]-MeVCN-treated rats than in those treated with 2-[' 4 C]VCN.
Distribution of Radioactivity 8 hr Following Treatment
Eight hours following 2-[ l4 C]VCN administration, the contents of the large intestine, especially the cecum, had the highest I4 C levels (Fig. 2a) . Liver, lung, bone marrow (femur and vertebra), and spleen contained similar levels of radioactivity. Quantitatively, the I4 C level in the liver was lower at 8 hr than at 5 min following treatment. Localization of 2-[ 14 C]VCN or its metabolites in adipose tissues, hair follicles, thyroid, adrenal, salivary, and Harderian glands, and epididymis was also observed. Although VCN-derived 14 C concentration in the blood declined, that in the bone marrow 
Note. Values are means ± SD of at least 40 determinations selected from four rats per period. " Not identified in the analyzed autoradiographs.
nearly doubled during this period (Table 1) . In these animals, Radioactivity derived from 2-[ l4 C]MeVCN 8 hr following low levels of I4 C were retained in the kidney, blood vessels, treatment was localized mainly in the intestinal mucosa, inbrain, and testis. testinal contents, and liver (Fig. 2b , Table 2 ). Considerable ± 1 7 ± 2 22 ± 2 39 ± I 1 14 ± 2 7 ± 1 125 ± 30 24 ± 2 9 ± I 19 ± 7 43 ± 8 82 ± 3 9 ± 2 3 ± 1 13 ± 2
Note. Values are means ± SD of at least 40 determinations selected from four rats per period° Not clearly identified in the analyzed autoradiographs. 4 C]MeVCN Note the high retention of radioactivity in the liver and gastric and nasal mucosa I4 C uptake was also observed in the thyroid, lacrimal, and salivary glands (parotid, maxillary, and submandibular), adrenal cortex, bone marrow, spleen, and skin. The MeVCNderived 14 C level in blood was decreased from the 5-min level. Moderate levels of 14 C in the epididymis and seminal vesicles of MeVCN-treated rats were observed at this period. In these animals, brain, spinal cord, and testis contained levels of radioactivity that were lower than levels of most of the other organs.
The above observations indicated that the radioactivity levels in the lungs, liver, spleen, and bone marrow of MeVCN-treated animals were lower than in 2-[ 14 C]VCNtreated rats (Fig. 2a, Tables 1 and 2 ). The data in Table 2 also indicate that 8 hr following treatment, rats that received 2-[ l4 C]MeVCN showed increased retention of radioactivity in the gastrointestinal mucosa and salivary, adrenal, thymus, and lacrimal glands.
Distribution of Radioactivity 24 hr Following Treatment
Progressive accumulation of I4 C in spleen and bone marrow was observed in animals treated with 2-[ l4 C]VCN (Fig.   3a , Table 1 ). While I4 C levels in the large intestine declined, considerable retention of 14 C in the lacrimal, Harderian (not shown), and thyroid glands, lungs, and adipose tissues occurred. In these animals, the epididymis contained more radioactivity than the testis.
Radioactivity derived from 2-[' 4 C]MeVCN 24 hr after treatment was retained in the lacrimal gland, liver, gastrointestinal mucosa, and intestinal contents (Fig. 3b, Table 2 ). Quantitatively, a progressive although slight uptake of radioactivity in the thymus was also observed (Table 2) . Bone marrow, spleen, kidney, adrenal cortex, stomach mucosa (not shown), adipose tissue, and epididymis retained low levels of radioactivity. Compared with other organs, lower levels of 14 C were retained by brain and testicular tissues at this period.
The autoradiographs of rat sections 24 hr after treatment indicated that there were qualitative and quantitative differences in the disposition of both compounds. There was less retention of 14 C in the livers of rats treated with 2-[ l4 C]-MeVCN (Fig. 3b) than in those treated with 2-[ l4 C]VCN (Fig. 3a) . Also, the lungs of VCN-treated rats retained more radioactivity than lungs of rats treated with MeVCN. Uptake in thymus, adrenal gland, and gastrointestinal mucosa was higher in MeVCN-treated animals compared with the VCNtreated group (Tables 1 and 2 ).
Distribution of Radioactivity 48 hr Following Treatment
The autoradiographs in Fig. 4a and the data in Table 1 indicate that the liver, bone marrow, spleen, large intestine, and lungs were organs with high I4 C retention 48 hr after the administration of 2-[' 4 C]VCN. Thyroid, adipose tissue, kidney, epididymis, skin, and salivary gland also contained I4 C at this period. Testis, brain, and spinal cord, however, retained the least levels of radioactivity.
In general, 48 hr after 2-[ l4 C]MeVCN administration, the radioactivity in most tissues was lower than that after 2-[ l4 C]VCN treatment. Tissues that retained the most radioactivity 48 hr after 2-[ l4 C]MeVCN treatment were the liver, lacrimal gland, nasal mucosa, and thymus (Fig. 4b , Table 2 ).
The retention, of radioactivity in the liver, spleen, bone marrow, and adipose tissues in VCN-treated rats was distinctively higher than that in the corresponding organs following 
Irreversible Interaction and or Incorporation of Radioactivity into Organs
Incorporation of radioactivity into the spleen, liver, bone marrow, and lung of 2-[' 4 C]VCN-treated rats is indicated in Fig. 5a . The autoradiographs of 2-[ 14 C]MeVCN-treated rats indicated the irreversible incorporation of I4 C into the gastrointestinal mucosa, lacrimal gland, liver, bone marrow, and thymus (Fig. 5b) . Comparison of the autoradiographs in Figs. 5a and b indicates that, following treatment with either compound, radioactivity derived from 2-[ l4 C]VCN is highly retained in the tissues as compared with that derived from 2-[' 4 C]MeVCN. Table 3 depicts the quantitative levels of irreversibly incorporated or bound radioactivity derived from either compound. In the initial period following treatment, much of the I4 C was bound to the lung tissues, but radioactivity declined as time elapsed. Forty-eight hours after treatment, high levels of irreversibly bound I4 C were observed in the lung tissues of VCN-treated rats, whereas the lungs C]MeVCN treated rats contained very low levels of radioactivity. In rats treated with VCN, considerable levels of irreversibly incorporated radioactivity were also observed in the liver, spleen, and bone marrow. Meanwhile, irreversible incorporation of radioactivity was observed only in liver and intestinal mucosa of rats treated with MeVCN.
Elimination of Radioactivity Following 2-[ l4 C]VCN or 2-["C]MeVCN Administration
The levels of radioactivity in the expired air, urine, and feces over a period of 48 hr following intravenous administration of either compound were determined (Table 4 ). In rats that received 2-[' 4 C]VCN, only 2% of the total radioactive dose was expired as 14 CO 2 , whereas in rats that received 2-[ l4 C]MeVCN, the rate of I4 C exhalation was remarkably higher. Approximately 37% of the total administered radioactive dose was expired as I4 CO 2 , and the majority (82%) of I4 CO 2 exhalation occurred during the initial 8 hr. Rats treated with 2-[ l4 C]VCN did not exhale any I4 C as parent compound. Conversely, rats treated with 2-[' 4 C]MeVCN expired 3% of the total 14 C dose as the parent compound. Renal and fecal excretions of radioactivity following treatment with either compound were also quantitatively different (Table 4 ). Approximately 4% of the total I4 C dose was excreted in the urine of 2-[ l4 C]VCN-treated rats, whereas the amount of 14 C detected in the urine of rats treated with 2-[' 4 C]MeVCN was more than 15% of the dose. About 20% of the total 2-[ 14 C]VCN dose was excreted in the feces over 48 hr, whereas in 2-[ l4 C]MeVCN-treated rats, fecal excretion of radioactivity accounted for only 10% of the dose.
DISCUSSION
The current study indicates that considerably high levels of radioactivity were detected in the hepatic tissues of VCNtreated rats. These levels were higher than those registered in the corresponding tissues of Me VCN-treated animals (Fig.  2) . Tardif et al. (1987) reported that the fast delivery of VCN to the liver following systemic administration may lead to pronounced formation of conjugates of VCN or its metabolites that are readily excreted in the bile (Ghanayem and Ahmed, 1982) . Contrary to VCN, minimal conjugation and biliary excretion of MeVCN or its metabolites were reported (Ghanayem etai, 1994) . Fecal excretion of radioactivity following oral administration of either compound was twice higher in VCN-treated animals as compared with those treated with MeVCN . The considerable difference in the magnitude of hepatic conjugation and biliary and fecal excretion of both compounds may have been due to the structural variability. As demonstrated in Fig. 6 , the electron-withdrawing ability of the cyano group creates an uneven distribution of the ir electrons in the vinylic double bond of the VCN molecule, rendering the /?-carbon atom strongly electrophilic (Ahmed and Trieff, 1983) . The /3-carbon atom becomes susceptible to rapid nucleophilic addition reactions, such as Michael addition, with nucleophilic molecules (Ghanayem and Ahmed, 1983; Kedderis et al, 1995) . McCarthy et al. (1994) reported that a-methyl substitution on the vinylic double bond of methyl acrylate ester to form a-methyl methacrylate significantly decreased its electrophilic activity toward the nucleophilic sulfhydryl group of GSH. The decreased reactivity may be due to a combination of steric and electronic factors. The electron-donating amethyl substituent sterically hinders nucleophilic addition on the /3-carbon atom of a-methyl methacrylate and decreases the partial positive charge on the /3-carbon atom, rendering it less electrophilic (Morrison and Boyd, 1963) . Accordingly, the electron-donating ability of the methyl group in MeVCN may have compensated for the electron- withdrawing properties of the cyano group, causing a decrease in the electrophilicity of the /3-carbon atom of the vinylic double bond. This effect creates an even electron cloud on the IT bond (Fig. 6 ) and renders MeVCN less susceptible to conjugation and subsequent diminished biliary and fecal excretion, as compared with VCN (data not shown).
The current study also indicates that following administration of MeVCN to rats approximately 40% of the radioactive dose was detected in various forms in exhaled air. Following intravenous administration of 2-[ l4 C]VCN, however, a small fraction (2.2%) of the total radioactive dose was oxidized to 14 CO 2 as detected in expired air. The metabolic profiles for VCN and MeVCN following oral administration Burka et al, 1994; Ghanayem et al, 1992) were similar to those reported in the current study. These similarities indicate that the route of administration had little effect on the qualitative elimination of VCN and MeVCN. The observed quantitative differences may thus be related to the chemical structure of both compounds. Methyl substitution increases the lipophilicity of organic molecules (Camarata and Martin, 1970) . Therefore, methyl substitution on VCN to form MeVCN may render the molecules more lipophilic as compared with the hydrophilic VCN molecules (Teo et al, 1994) . The increased lipophilicity of MeVCN may have enhanced its accessibility to the lipophilic active sites of oxidative enzyme systems, leading to increased oxidative metabolism of MeVCN as compared with VCN.
Toxicological studies have indicated that VCN injures the gastrointestinal mucosa following oral and systemic administration (Ghanayem and Ahmed, 1983; Abdel-Rahman et al, 1994) . It was concluded that VCN toxicity may be mediated by the infiltration of a bloodborne metabolite(s) into the gastrointestinal mucosa and not due to a direct irritation mechanism. The current study supports this hypothesis and shows that both VCN and MeVCN or their metabolites accu-mulated in the gastrointestinal mucosa following intravenous administration. MeVCN, however, had a higher magnitude of accumulation in the gastrointestinal mucosa than did VCN. Currently, there are no reports on gastrointestinal pathology of MeVCN.
The accumulation of both VCN-and MeVCN-derived radioactivity in the hematopoietic tissues (e.g., spleen, bone marrow) was delayed but progressive, and was highest 24 and 48 hr after treatment. The magnitude of irreversible accumulation of 14 C derived from VCN in these tissues was much higher than that for MeVCN. Little is known about the impact of these chemicals on the hematopoietic system. Ahmed et al. (1992) have indicated that VCN causes injury and increases DNA damage in the pulmonary tissues of VCN-treated rats. The uptake and elimination of radioactivity by the lung and nasal turbinates for both compounds were different. Although 14 C derived from MeVCN continuously passed through the lung, accumulation and irreversible interaction of radioactivity in this organ following MeVCN treatment were considerably lower than observed following 2-[' 4 C]VCN treatment. These phenomena may have been caused by bioactivation of VCN by pulmonary enzymes as described before (Roberts et al., 1989) .
In conclusion, the results of the present study provided a comparison of the biological fate of two structurally related a-P unsaturated nitriles. Addition of a methyl group to VCN in the a position, to form MeVCN, resulted in faster oxidation and elimination via exhaled air, which together alleviated the biological fate in rats. Compared with MeVCN, VCN metabolites were extensively excreted in the intestinal contents and feces and had a tendency to accumulate irreversibly in the liver, lung, and bone marrow.
